Overview

Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants

Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
Clinical study with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tacrolimus + mycophenolate mofetil in renal transplant patients in the maintenance phase.
Phase:
Phase 4
Details
Lead Sponsor:
Edoardo Melilli
Treatments:
Everolimus
Mycophenolic Acid
Sirolimus
Tacrolimus